This Week In Wellness a review published in the Biomolecules journal has suggested that melatonin may be more effective in reducing long covid symptoms and COVID-19 inflammatory markers than commonly used antivirals. The authors have suggested that the reason it has not been promoted more as a solution is due to it’s easy availability and the fact that it cannot be patented by pharmaceutical manufacturers.